Detalhe da pesquisa
1.
Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.
Br J Clin Pharmacol
; 90(5): 1301-1311, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369687
2.
Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry.
Surg Endosc
; 34(3): 1112-1122, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31144122
3.
Correction to: Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry.
Surg Endosc
; 34(3): 1123, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292741
4.
Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study.
Am J Gastroenterol
; 111(3): 411-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26856753
5.
Outcome after a dose "de-intensification" strategy with anti-TNF drugs in patients with Crohn's disease.
Gastroenterol Hepatol
; 39(4): 255-60, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26620278
6.
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.
Therap Adv Gastroenterol
; 17: 17562848231221713, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187926
7.
Endoscopic treatment (endoscopic balloon dilation/self-expandable metal stent) vs surgical resection for the treatment of de novo stenosis in Crohn's disease (ENDOCIR study): an open-label, multicentre, randomized trial.
Trials
; 24(1): 432, 2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365665
8.
Self-expandable metal stents versus endoscopic balloon dilation for the treatment of strictures in Crohn's disease (ProtDilat study): an open-label, multicentre, randomised trial.
Lancet Gastroenterol Hepatol
; 7(4): 332-341, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065738
9.
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry.
J Crohns Colitis
; 16(6): 946-953, 2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34864947
10.
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.
J Clin Med
; 11(15)2022 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35956133
11.
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
Inflamm Bowel Dis
; 28(11): 1725-1736, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35166347
12.
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry.
J Crohns Colitis
; 15(11): 1846-1851, 2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860795
13.
Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu.
J Clin Med
; 10(19)2021 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34640421
14.
Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry.
J Crohns Colitis
; 14(9): 1290-1298, 2020 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32201893
15.
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
Inflamm Bowel Dis
; 26(4): 606-616, 2020 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504569
16.
Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis.
Hepatology
; 48(6): 1924-31, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19003911
17.
[Use of adalimumab in a patient with Crohn's disease and extensive generalised psoriasis who achieved complete remission of both conditions]. / Uso de adalimumab en una paciente con enfermedad de Crohn y psoriasis cutánea generalizada extensa que alcanza la remisión completa de las 2 enfermedades.
Gastroenterol Hepatol
; 36(6): 396-9, 2013.
Artigo
em Espanhol
| MEDLINE | ID: mdl-23587662
18.
New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis
; 24(12): 2555-2564, 2018 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30099509
19.
Evaluation of 5 versus 10 granulocyteaphaeresis sessions in steroid-dependent ulcerative colitis: a pilot, prospective, multicenter, randomized study.
World J Gastroenterol
; 13(15): 2193-7, 2007 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-17465500
20.
Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype.
World J Gastroenterol
; 13(41): 5446-53, 2007 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-17907287